News: FDA Warning Letter to Chinese Company Cites Cross-Contamination Concerns

API manufacturer Sichuan Pharmaceutical Co. in Pengzhou, Sichuan, China received a warning letter in early September, 2011, based on issues that FDA investigators found during a June, 2010 inspection related to potential cross-contamination risks.